Twin Peaks Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179K Buy
+509
New +$181K 0.05% 200
2025
Q3
Sell
-365
Closed -$104K 255
2025
Q2
$104K Buy
+365
New +$103K 0.03% 231

Other funds holding AMGN

Twin Peaks Wealth Advisors's AMGN Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in Amgen (AMGN) in Q1 2026: 509 shares worth $179K. The stake represents 0.05% of the portfolio and ranks #200 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in AMGN as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in AMGN in Q2 2025 and has held it in 2 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Twin Peaks Wealth Advisors held 509 shares of Amgen worth $179K as of Q1 2026.
  • Amgen was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • Amgen made up 0.05% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #200 holding.
  • Twin Peaks Wealth Advisors first reported a position in Amgen in Q2 2025 and has held it in 2 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.